Clinical Trial Update: Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating drug activity in women with breast cancer who have not previously received Herceptin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Breast Neoplasm | Phase 1 | Status: TERMINATED